PRIMARY IMMUNE THROMBOCYTOPENIA
Clinical trials for PRIMARY IMMUNE THROMBOCYTOPENIA explained in plain language.
Never miss a new study
Get alerted when new PRIMARY IMMUNE THROMBOCYTOPENIA trials appear
Sign up with your email to follow new studies for PRIMARY IMMUNE THROMBOCYTOPENIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug shows promise for controlling rare bleeding disorder
Disease control CompletedThis study tested the long-term safety and effectiveness of a drug called efgartigimod for adults with primary immune thrombocytopenia (ITP), a condition where the immune system attacks platelets, increasing bleeding risk. Over 100 patients received intravenous infusions for up t…
Matched conditions: PRIMARY IMMUNE THROMBOCYTOPENIA
Phase: PHASE3 • Sponsor: argenx • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
Scientists probe brain fog and fatigue in blood disorder patients
Knowledge-focused CompletedThis study aims to understand how often adults with chronic immune thrombocytopenia (ITP) experience problems with thinking, memory, and fatigue. Researchers will collect information from medical records and blood tests from about 100 participants to look for links between these …
Matched conditions: PRIMARY IMMUNE THROMBOCYTOPENIA
Sponsor: Sanofi • Aim: Knowledge-focused
Last updated Apr 01, 2026 23:41 UTC